Meta AnalysisID 7288
膳食花青素对代谢综合征相关危险因素的影响：一项系统评价与Meta分析
CRD42023448429
Effect of dietary anthocyanins on the Risk factors related to metabolic syndrome: A Systematic Review and Meta-analysis
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7288
- Evidence Id
- 15846
- Core Evidence Id
- 15846
- Source Meta Analysis Id
- 7273
- Herb2 Meta Analysis Id
- HBMA007273
- Crd Id
- CRD42023448429
- Title
- Effect of dietary anthocyanins on the Risk factors related to metabolic syndrome: A Systematic Review and Meta-analysis
- Review Question
- Effect of dietary anthocyanins on the Risk factors related to metabolic syndrome: A Systematic Review and Meta-analysis
- Study Type Included
- The literature that will compare outcomes between anthocyanin-containing and anthocyanin-free supplements in healthy adults or individuals with risk factors of MetS will be included. The outcomes will include pre-intervention, post-intervention, functional, and effect outcomes. The exclusion criteria will be as follows: (a) non-human studies; (b) non-original studies (letters, reviews, editorials); (c) Did not design study appropriately (not RCT); (d) Did not report the relevant results and insufficient data; (e) Did not report anthocyanins dose; (f) Did not publish component of placebo and control group contain anthocyanins; (g) Report duplicate results.
- Condition Being Studied
- Metabolic syndrome (MetS) was described in 1988 and refers to the metabolic abnormalities of the body, mainly including glucose intolerance, insulin resistance, central obesity, dyslipidaemia, and hypertension. The study focuses on interventions involving both anthocyanin-containing and anthocyanin-free supplements in healthy adults or those with risk factors of MetS.
- Participant
- The literature that will compare outcomes between anthocyanin-containing and anthocyanin-free supplements in healthy adults or individuals with risk factors of MetS will be included. Study participants were aged 18 years or older and were either healthy or had risk factors of MetS. The exclusion criteria will be as follows: (a) non-human studies; (b) non-original studies (letters, reviews, editorials); (c) Did not design study appropriately; (d) Did not report the relevant results and insufficient data; (e) Did not report anthocyanins dose; (f) Did not publish component of placebo and control group contain anthocyanins; (g) Report duplicate results.
- Animal
- Human Disease Modelled
- Intervention
- Participants received intervention with anthocyanin-containing supplements, either healthy or with risk factors of MetS.
- Comparator Control
- Participants received intervention with anthocyanin-free supplements, either healthy or with risk factors of MetS.
- Main Outcome
- Functional outcome: anthropometric parameters (body mass index (BMI), waist circumference (WC)), lipid profiles (triglyceride (TG), high-density lipoprotein cholesterol (HDL-C)), blood pressure (systolic blood pressure (SBP), diastolic blood pressure (DBP)) (BP), glycemic status (Fasting Blood Glucose (FBG)), homeostasis model assessment insulin resistance index (HOMA-IR). Measures of effect The weighted mean difference (WMD) and 95% CI will be calculated for the same methods and same units continuous outcomes. The standardized mean difference (SMD) and 95% CI will be calculated for different methods or with different units continuous outcomes.
- Outcome Measure
- Additional Outcome
- Functional outcome: anthropometric parameters (weight), lipid profiles (total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C)), glycemic status (insulin, glycated hemoglobin (HbA1c)). Measures of effect The weighted mean difference (WMD) and 95% CI will be calculated for the same methods and same units continuous outcomes. The standardized mean difference (SMD) and 95% CI will be calculated for different methods or with different units continuous outcomes.
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Anthocyanins; Diet; Humans; Metabolic Syndrome; Risk Factors
- Contact
- Junyin Pan [email protected]
- Organisational Affiliation
- Heilongjiang University of Chinese Medicine http://www.hljucm.net/
- Funding Source
- - Funding Source(s) or Sponsor(s): Research Project Funded by Heilongjiang Administration of Traditional Chinese Medicine - Description: The Heilongjiang Administration of Traditional Chinese Medicine provided funding to support this review. Grant number(s) State the funder, grant or award number and the date of award - Funder: Heilongjiang Administration of Traditional Chinese Medicine - Grant or Award Number: ZHY2020-078 - Date of Award: July 8, 2020
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-07-29
- Registration Date
- 2023-08-10
- Anticipated Start Date
- 2023-07-30
- Anticipated Completion Date
- 2023-12-30
- Title Cn
- 膳食花青素对代谢综合征相关危险因素的影响：一项系统评价与Meta分析
- Title En
- Effect of dietary anthocyanins on the Risk factors related to metabolic syndrome: A Systematic Review and Meta-analysis
- Bilingual Status
- complete